TipRanks
Go Ultimate55% OFF

ETFs with ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Exposure

The following ETFs maintain exposure to ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541). ETF holdings data are updated once a day, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.

2 ETFs Hold ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541)

ETFs holding HK:1541
SymbolETF NameAUMExpense Ratio% Weight in ETFMarket Value% Weight in 1541
GXCSPDR S&P China ETF$420.87M0.59%<0.01%$28.90K0.02%
SPEMSPDR Portfolio Emerging Markets ETF$16.38B0.07%<0.01%$267.50K0.17%
Find ETFs with the TipRanks ETF screener

Popular ETFs

Popular ETFs
CompanyPrice & ChangeFollow
SPYSPDR S&P 500 ETF Trust―
QQQInvesco QQQ Trust―
DIASPDR Dow Jones Industrial Average ETF Trust―
IWMiShares Russell 2000 ETF―
VOOVanguard S&P 500 ETF―

1541 ETF Exposure FAQ

What ETFs hold ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H stock?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) is currently held by 2 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to HK:1541 include State Street (SPEM) and State Street (GXC).
Which ETF has the largest exposure to HK:1541?
The ETF with the largest exposure to HK:1541 is State Street (SPEM), with approximately HKD 267.50K in market value exposure.
How much HK:1541 stock is held by ETFs?
ETFs currently hold approximately HKD 296.40K worth of ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.